Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Summary

This is a randomized placebo controlled trial. Malaria chemoprophylaxis with mefloquine in asymptomatic HIV-infected adults living in a malaria endemic region of Luanshya, Zambia will be compared to a placebo control group and followed up for 18 months.

Timeline

Start

2005-10

Primary completion

2007-12

Completion

2011-05

Drugs

Indications